Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886 · see citing works

A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM

Berg, K. (1963) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1963.tb01808.x · Cited by 1,377 · see citing works

Lipoprotein(a), fibrin binding, and plasminogen activation.

Loscalzo, J., Weinfeld, M. S., Fless, G. M., & Scanu, A. M. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.2.240 · Cited by 461 · see citing works

Lipoprotein (a) and Genetic Polymorphisms of Clotting Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Are Risk Factors of Spontaneous Ischemic Stroke in Childhood

Nowak‐Göttl, U., Sträter, R., Heinecke, A., Junker, R., Koch, H.-G., Schuierer, G. R., & von Eckardstein, A. (1999) · Blood · doi:10.1182/blood.v94.11.3678 · Cited by 343 · see citing works

Prospective assessment of risk factors for recurrent stroke during childhood-a 5-year follow-up study

Sträter, R., Becker, S., von Eckardstein, A., Heinecke, A., Gutsche, S., Junker, R., Kurnik, K., Schobeß, R., & Nowak‐Göttl, U. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11520-0 · Cited by 333 · see citing works

Molecular definition of the extreme size polymorphism in apolipoprotein(a)

Lackner, C., Cohen, J. C., & Hobbs, H. H. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.933 · Cited by 320 · see citing works

Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors

Nowak‐Göttl, U. (2001) · Blood · doi:10.1182/blood.v97.4.858 · Cited by 252 · see citing works

Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis

Caplice, N. M., Panetta, C. J., Peterson, T. E., Kleppe, L. S., Mueske, C. S., Kostner, G. M., Broze, G., & Simari, R. D. (2001) · Blood · doi:10.1182/blood.v98.10.2980 · Cited by 228 · see citing works

Increased Lipoprotein(a) Is an Important Risk Factor for Venous Thromboembolism in Childhood

Nowak‐Göttl, U., Junker, R., Hartmeier, M., Koch, H.-G., Münchow, N., Assmann, G., & von Eckardstein, A. (1999) · Circulation · doi:10.1161/01.cir.100.7.743 · Cited by 222 · see citing works

The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms

van der Hoek, Y. Y., Wittekoek, M. E., Beisiegel†, U., Kastelein, J. J. P., & Koschinsky, M. L. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.4.361 · Cited by 183 · see citing works

Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism

von Depka, M., Nowak‐Göttl, U., Eisert, R. M., Dieterich, C., Barthels, M., Scharrer, I., Ganser, A., & Ehrenforth, S. (2000) · Blood · doi:10.1182/blood.v96.10.3364 · Cited by 174 · see citing works

Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

Palabrica, T. M., Liu, A. C., Aronovitz, M. J., Furie, B., Lawn, R. M., & Furie, B. C. (1995) · Nature Medicine · doi:10.1038/nm0395-256 · Cited by 161 · see citing works

Inhibition of Plasminogen Activation by Lipoprotein(a)

Hancock, M. A., Boffa, M. B., Marcovina, S. M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302780200 · Cited by 153 · see citing works

Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature

Marcovina, S. M., Hobbs, H. H., & Albers, J. J. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.3.436 · Cited by 130 · see citing works

Inhibition of Fibrinolysis by Lipoprotein(a)

Anglés‐Cano, E., de la Peña-Dı́az, A., & Loyau, S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03514.x · Cited by 124 · see citing works

Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator

Edelberg, J. M., Gonzalez–Gronow, M., & Pizzo, S. V. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90203-o · Cited by 111 · see citing works

Identification of Two Functionally Distinct Lysine-binding Sites in Kringle 37 and in Kringles 32−36 of Human Apolipoprotein(a)

Ernst, A., Helmhold, M., Brunner, C., Pethö‐Schramm, A., Armstrong, V. W., & Müller, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6227 · Cited by 101 · see citing works

Apolipoprotein(a) Enhances Platelet Responses to the Thrombin Receptor–Activating Peptide SFLLRN

Rand, M. L., Sangrar, W., Hancock, M. A., et al. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.9.1393 · Cited by 84 · see citing works

The Recurring Evolution of Lipoprotein(a)

Lawn, R. M., Boonmark, N. W., Schwartz, K., Lindahl, G. E., Wade, D. P., Byrne, C. D., Fong, K. J., Meer, K., & Patthy, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24004 · Cited by 83 · see citing works

Transgenic Rabbits Expressing Human Apolipoprotein(a) Develop More Extensive Atherosclerotic Lesions in Response to a Cholesterol-Rich Diet

Fan, J., Shimoyamada, H., Sun, H., Marcovina, S. M., Honda, K., & Watanabe, T. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.88 · Cited by 82 · see citing works

Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.

Libourel, E. J., Bank, I., Meinardi, J. R., Volkers, C., Hamulyák, K., Middeldorp, S., Koopman, M. M. W., Pampus, E. C. M. V., Prins, M. H., Buller, H. R., et al. (2002) · PubMed · Cited by 79 · see citing works

Lipoprotein(a) Assembly

Gabel, B. R., May, L. F., Marcovina, S. M., & Koschinsky, M. L. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1559 · Cited by 77 · see citing works

Analysis of the Proteolytic Activity of a Recombinant Form of Apolipoprotein(a)

Gabel, B. R., & Koschinsky, M. L. (1995) · Biochemistry · doi:10.1021/bi00048a023 · Cited by 76 · see citing works

Lipoprotein(a) Enhances Advanced Atherosclerosis and Vascular Calcification in WHHL Transgenic Rabbits Expressing Human Apolipoprotein(a)

Sun, H., Unoki‐Kubota, H., Wang, X., Liang, J., Ichikawa, T., Arai, Y., Shiomi, M., Marcovina, S. M., Watanabe, T., & Fan, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205814200 · Cited by 75 · see citing works

Antifibrinolytic Effect of Recombinant Apolipoprotein(a) in Vitro Is Primarily Due to Attenuation of tPA-Mediated Glu-Plasminogen Activation

Sangrar, W., Bajzar, L., Nesheim, M. E., et al. (1995) · Biochemistry · doi:10.1021/bi00015a028 · Cited by 67 · see citing works

Sequences within Apolipoprotein(a) Kringle IV Types 6−8 Bind Directly to Low-Density Lipoprotein and Mediate Noncovalent Association of Apolipoprotein(a) with Apolipoprotein B-100

Gabel, B. R., & Koschinsky, M. L. (1998) · Biochemistry · doi:10.1021/bi973186w · Cited by 59 · see citing works

Plasma Lp(a) Levels Are Increased in Patients with Chronic Thromboembolic Pulmonary Hypertension

Ignatescu, M. C., Zorn, G., Kneußl, M., et al. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615178 · Cited by 58 · see citing works

The Solution Phase Interaction between Apolipoprotein(a) and Plasminogen Inhibits the Binding of Plasminogen to a Plasmin-Modified Fibrinogen Surface

Sangrar, W., Gabel, B. R., Boffa, M. B., et al. (1997) · Biochemistry · doi:10.1021/bi962433d · Cited by 57 · see citing works

Apolipoprotein(a) Attenuates Endogenous Fibrinolysis in the Rabbit Jugular Vein Thrombosis Model In Vivo

Biemond, B. J., Friederich, P. W., Koschinsky, M. L., et al. (1997) · Circulation · doi:10.1161/01.cir.96.5.1612 · Cited by 56 · see citing works

Lp(a) Particles Mold Fibrin-Binding Properties of Apo(a) in Size-Dependent Manner

Kang, C., Domínguez, M., Loyau, S., et al. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000021144.87870.c8 · Cited by 49 · see citing works

Occlusive arterial thrombosis in cynomolgus monkeys with varying plasma concentrations of lipoprotein(a).

Williams, J. K., Bellinger, D. A., Nichols, T. C., et al. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.4.548 · Cited by 48 · see citing works

Lipoprotein(a) and atherogenesis

Liu, A. C., & Lawn, R. M. (1994) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(94)90024-8 · Cited by 45 · see citing works

A Critical Evaluation of the Role of Lp(a) in Cardiovascular Disease: Can Lp(a) Be Useful in Risk Assessment?

Marcovina, S. M., & Koschinsky, M. L. (2002) · Seminars in Vascular Medicine · doi:10.1055/s-2002-35404 · Cited by 43 · see citing works

Thromboembolism in children

Nowak‐Göttl, U., Kosch, A., Schlegel, N., et al. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200209000-00010 · Cited by 42 · see citing works

Lipoprotein(a) concentration is not associated with venous thromboembolism in a case control study.

Lippi, G., Bassi, A., Brocco, G., et al. (1999) · PubMed · Cited by 39 · see citing works

Cloning, expression, and characterization of human apolipoprotein(a) kringle IV37.

LoGrasso, P. V., Cornell-Kennon, S., & Boettcher, B. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31877-x · Cited by 35 · see citing works

Higher lipoprotein (a) levels in atherothrombotic than lacunar ischemic cerebrovascular disease

Cerrato, P., Imperiale, D., Fornengo, P., et al. (2002) · Neurology · doi:10.1212/wnl.58.4.653 · Cited by 34 · see citing works

Lipoprotein(a), Other Lipoproteins and Hemostatic Profiles in Patients with Ischemic Stroke: The Relation to Cardiogenic Embolism

Dahl, T., Kontny, F. P., Slagsvold, C. E., et al. (2000) · Cerebrovascular Diseases · doi:10.1159/000016039 · Cited by 34 · see citing works

Comparative Analyses of the Lysine Binding Site Properties of Apolipoprotein(a) Kringle IV Types 7 and 10

Rahman, M. N., Becker, L., Petrounevitch, V., et al. (2001) · Biochemistry · doi:10.1021/bi010964i · Cited by 31 · see citing works

Influence of Lipoprotein (a) Levels and Isoforms on Fibrinolytic Activity – Study in Families with High Lipoprotein (a) Levels

Falcó, C., Dalmau, J., España, F., et al. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615071 · Cited by 30 · see citing works

Hypofibrinolysis, Lipoprotein(a), and Plasminogen Activator Inhibitor

Berger, C. E., ner, A. K., Stiegler, H., et al. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200204000-00039 · Cited by 23 · see citing works

Lipoprotein(a), Left Atrial Appendage Function and Thromboembolic Risk in Patients With Chronic Nonvalvular Atrial Fibrillation

Igarashi, Y., Kasai, H., Yamashita, F., Sato, T., Inuzuka, H., Ojima, K., & Aizawa, Y. (2000) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.64.93 · Cited by 14 · see citing works

Transgenic Rabbits Expressing Human Apolipoprotein(a) as a Useful Model for the Study of Lipoprotein(a)a

Fan, J., Challah, M., Shimoyamada, H., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06336.x · Cited by 5 · see citing works

Serum Lipoprotein(a) and Its Relation to Left Ventricular Thrombus in Patients with Acute Myocardial Infarction.

Çelik, Ş., Baykan, M., Örem, C., et al. (2001) · Japanese Heart Journal · doi:10.1536/jhj.42.5 · Cited by 4 · see citing works

High Plasma Levels of Lipoprotein(a) in Uremic Patients are Related to Markers of Inflammation, and to Activated, not Impaired, Fibrinolysis

Gatica, A., Panes, O., Tagle, R., et al. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613278 · Cited by 2 · see citing works

Lipoprotein (a) and thrombogenesis in left ventricular dysfunction

Lip, G. Y. H. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2326 · Cited by 1 · see citing works

Lack of association between elevated serum Lp(a) and local thrombus lysability in patients with peripheral arterial occlusive disease

Roller, R. E., Trinker, M., Schnedl, W. J., et al. (1999) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199910000-00010 · Cited by 1 · see citing works

Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650 · see citing works

Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306 · see citing works

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works

Enigmatic role of lipoprotein(a) in cardiovascular disease.

Anuurad, E., Enkhmaa, B., & Berglund, L. (2010) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2010.00238.x · Cited by 14 · see citing works

Blood inhibitory capacity toward exogenous plasmin

Banbula, A., Zimmerman, T. P., & Novokhatny, V. V. (2007) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32808738b4 · Cited by 8 · see citing works

In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent

Knapp, J.-P., & Herrmann, W. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.205 · Cited by 9 · see citing works

Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin

Harpel, P. C., Gordon, B. R., & Parker, T. S. (1989) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(89)90176-8 · Cited by 56 · see citing works

Lipoprotein(a), Plasmin Modulation, and Atherogenesis

Harpel, P. C., Hermann, A., Zhang, X., Ostfeld, I., & Borth, W. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642707 · Cited by 43 · see citing works

Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.

Harpel, P. C., Gordon, B. R., & Parker, T. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3847 · Cited by 288 · see citing works